GlassScriptPhysician profile
Raul Calderon
NPI 1134396492
$817.81
in general payments reported to CMS, 2019-2025
9 companies · $747 in 2025
The $747 reported for 2025 was more than what 93% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.68 · 2023: $24.63 · 2024: $28.72 · 2025: $747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $800.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $243.34 | 2025 | General - Pain Management |
| Mimedx Group, INC. | $100.80 | 2025 | |
| Spr Therapeutics, INC | $93.93 | 2025 | Sprint Pns System |
| Medtronic, INC. | $93.93 | 2025 | Intellis Adaptivestim |
| Biotronik Nro, INC. | $76.22 | 2025 | Prospera |
| Mml US, INC. | $75.49 | 2025 | Reactiv8 |
| Convatec INC. | $63.07 | 2025 | |
| Merck Sharp & Dohme LLC | $53.35 | 2023-2024 | Bridion |
| Mallinckrodt Enterprises LLC | $17.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raul Calderon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.